Picard Medical, Inc.

Picard Medical, Inc.

AAMEX:PMI
7.24
USD
+0.01
(+0.14%)
-18.95EPS
16.80MMarket Cap

Total Valuation

USD

As of June 30, 2026, Picard Medical, Inc. carries a market capitalization of 16.80M, placing it among publicly traded companies globally. Its enterprise value stands at 18.34M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap16.80M
Enterprise Value18.34M

Important Dates

Picard Medical, Inc.'s next confirmed earnings release is scheduled for November 16, 2026.

Earnings Date11/16/2026

Share Statistics

As of June 30, 2026, Picard Medical, Inc. has 2.06M shares outstanding.

Shares Outstanding2.06M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 1.92, and the price-to-book ratio stands at 9.79.

PS Ratio1.92
PB Ratio9.79
P/TBV Ratio26.42
P/FCF Ratio-0.75
P/OCF Ratio-0.75

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 2.91 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 18.34M versus a market cap of 16.80M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.91

Financial Position

As of June 30, 2026, Picard Medical, Inc. maintains a current ratio of 1.02, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 91.96, indicating elevated leverage, while an interest coverage ratio of -6.03 demonstrates limited ability to service its debt obligations.

Current Ratio1.02
Quick Ratio0.09
Debt / Equity91.96
Debt / EBITDA-0.10
Interest Coverage-6.03

Financial Efficiency

USD

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -268.26, reflecting losses generated across the asset base. The company generates approximately 84,000.00 in revenue per employee across its workforce of 75.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.79 indicates how many times Picard Medical, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-268.26
Revenue Per Employee84,000.00
Employee Count75.00
Inventory Turnover0.79

Taxes

USD

Over the twelve months ended June 30, 2026, Picard Medical, Inc. recorded 11,000.00 in income tax expense. The company reported a pretax loss of -27.98M and -27.99M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax11,000.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Picard Medical, Inc.'s stock has declined approximately 94.64% over the past 52 weeks. The 50-day moving average sits at 7.49, while the 200-day moving average is 26.05.

52-Week Price Change-94.64%
50-Day Moving Average7.49
200-Day Moving Average26.05

Income Statement

USD

Over the twelve months ended June 30, 2026, Picard Medical, Inc. generated 6.30M in revenue and converted that into -27.99M in net income, yielding earnings per share of -18.95. EBITDA reached -15.10M, while operating income came in at -15.63M.

Revenue6.30M
Gross Profit1.17M
Operating Income-15.63M
Pretax Income-27.98M
Net Income-27.99M
EBITDA-15.10M
EBIT-15.63M
Earnings Per Share (EPS)-18.95

Balance Sheet

USD

As of June 30, 2026, Picard Medical, Inc. holds 38,000.00 in cash and equivalents against 1.58M in total debt, resulting in a net debt position of 1.23M. Total book value stands at 1.72M, with working capital of 141,000.00 providing operational flexibility.

Cash & Cash Equivalents38,000.00
Total Debt1.58M
Net Debt1.23M
Equity (Book Value)1.72M
Book Value Per Share0.83
Working Capital141,000.00

Cash Flow

USD

Picard Medical, Inc. produced -16.04M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -26,000.00 in capital expenditures, free cash flow totaled -16.07M - equivalent to -10.88 per share.

Operating Cash Flow-16.04M
Capital Expenditures-26,000.00
Free Cash Flow-16.07M
FCF Per Share-10.88

Margins

Over the twelve months ended June 30, 2026, Picard Medical, Inc. posted a gross margin of 18.60, reflecting its pricing power and cost economics. The operating margin of -248.10 and net profit margin of -444.33 provide insight into operational efficiency.

Gross Margin18.60
Operating Margin-248.10
Pretax Margin-444.16
Profit Margin-444.33
EBITDA Margin-239.67

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -133.09: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -93.38, meaning Picard Medical, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-93.38
FCF Yield-133.09

Stock Splits

Picard Medical, Inc.'s most recent stock split took place on August 3, 2026 with a 50:1 split ratio.

Last Split Date8/3/2026
Split Ratio50:1

Scores

As of June 30, 2026, Picard Medical, Inc. has an Altman Z-Score of -19.83, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-19.83